GB1043141A - Substituted-4-oxo-1, 3, 8-triazaspiro (4, 5) decanes and their therapeutically active non-toxic acid addition salts and the preparation thereof - Google Patents

Substituted-4-oxo-1, 3, 8-triazaspiro (4, 5) decanes and their therapeutically active non-toxic acid addition salts and the preparation thereof

Info

Publication number
GB1043141A
GB1043141A GB24824/63A GB2482463A GB1043141A GB 1043141 A GB1043141 A GB 1043141A GB 24824/63 A GB24824/63 A GB 24824/63A GB 2482463 A GB2482463 A GB 2482463A GB 1043141 A GB1043141 A GB 1043141A
Authority
GB
United Kingdom
Prior art keywords
chloro
fluorophenyl
phenyl
cyclopropyl
prepared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB24824/63A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Laboratorium C Janssen NV
Original Assignee
Research Laboratorium C Janssen NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Laboratorium C Janssen NV filed Critical Research Laboratorium C Janssen NV
Publication of GB1043141A publication Critical patent/GB1043141A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Wire Processing (AREA)
  • Hydrogenated Pyridines (AREA)
GB24824/63A 1962-06-22 1963-06-21 Substituted-4-oxo-1, 3, 8-triazaspiro (4, 5) decanes and their therapeutically active non-toxic acid addition salts and the preparation thereof Expired GB1043141A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20462362A 1962-06-22 1962-06-22

Publications (1)

Publication Number Publication Date
GB1043141A true GB1043141A (en) 1966-09-21

Family

ID=22758700

Family Applications (1)

Application Number Title Priority Date Filing Date
GB24824/63A Expired GB1043141A (en) 1962-06-22 1963-06-21 Substituted-4-oxo-1, 3, 8-triazaspiro (4, 5) decanes and their therapeutically active non-toxic acid addition salts and the preparation thereof

Country Status (9)

Country Link
BE (1) BE633914A (US06262066-20010717-C00359.png)
CH (1) CH462835A (US06262066-20010717-C00359.png)
DE (1) DE1470125C3 (US06262066-20010717-C00359.png)
DK (1) DK119880B (US06262066-20010717-C00359.png)
FI (1) FI46967C (US06262066-20010717-C00359.png)
FR (6) FR1573808A (US06262066-20010717-C00359.png)
GB (1) GB1043141A (US06262066-20010717-C00359.png)
NO (1) NO117368B (US06262066-20010717-C00359.png)
SE (1) SE311019B (US06262066-20010717-C00359.png)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2361889A1 (fr) * 1975-07-21 1978-03-17 Janssen Pharmaceutica Nv Nouveaux derives de 1-(benzazolyalcoyl)piperidine
US4080328A (en) * 1971-07-13 1978-03-21 Sumitomo Chemical Company, Limited N-substituted heterocyclic derivatives and preparation thereof
WO1999059997A1 (en) * 1998-05-18 1999-11-25 Novo Nordisk A/S Novel 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes
EP0997464A1 (en) * 1998-10-23 2000-05-03 Pfizer Inc. 1,3,8-Triazaspiro[4,5] decanone compounds as orl1-receptor agonists
US6277991B1 (en) 1998-05-18 2001-08-21 Novo Nordisk A/S 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes
US6716846B2 (en) * 1998-07-27 2004-04-06 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
US8394804B2 (en) 2001-10-19 2013-03-12 Janssen Pharmaceutica N.V. Phosphonic acid compounds as inhibitors of serine proteases
EP3138841A1 (en) * 2010-06-18 2017-03-08 Altos Therapeutics, LLC D2 antagonists, methods of synthesis and methods of use
IT201800007580A1 (it) * 2018-07-27 2020-01-27 Maria Cecilia Hospital Spa Composti 1,3,8-triazaspiro e loro uso come medicamenti

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792187A (fr) * 1971-12-03 1973-03-30 Sumitomo Chemical Co Nouveaux derives d'alkylamines
NZ181256A (en) * 1975-07-21 1978-04-28 Janssen Pharmaceutica Nv 1-(w-benzazol-11-ylalkyl)-piperidine derivatives and pharmaceutical compositions containing certain of these derivatives
DK139684A (da) * 1983-04-11 1984-10-12 Janssen Pharmaceutica Nv N-aryl-alpha-amino-carboxamider
US5703088A (en) * 1989-08-21 1997-12-30 Beth Israel Deaconess Medical Center, Inc. Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses
US5244902A (en) * 1989-08-21 1993-09-14 Beth Israel Hospital Association Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses
US5574041A (en) * 1990-03-16 1996-11-12 Beth Israel Hospital Association Use of spiperone derivatives as immunosuppressant agents
US5693645A (en) * 1992-12-23 1997-12-02 Beth Israel Deaconess Medical Center, Inc. Use of spiperone or spiperone derivatives as immunosuppressant agents
DE19610397A1 (de) * 1996-03-16 1997-09-18 Krewel Meuselbach Gmbh Gewinnung von Fluspirilen-Suspensionen
DE102005038141A1 (de) * 2005-08-12 2007-02-15 Grünenthal GmbH Substituierte 8-(3-Aminopropyl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-on-Derivate

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4080328A (en) * 1971-07-13 1978-03-21 Sumitomo Chemical Company, Limited N-substituted heterocyclic derivatives and preparation thereof
FR2361889A1 (fr) * 1975-07-21 1978-03-17 Janssen Pharmaceutica Nv Nouveaux derives de 1-(benzazolyalcoyl)piperidine
WO1999059997A1 (en) * 1998-05-18 1999-11-25 Novo Nordisk A/S Novel 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes
US6277991B1 (en) 1998-05-18 2001-08-21 Novo Nordisk A/S 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes
US6716846B2 (en) * 1998-07-27 2004-04-06 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
US7094784B2 (en) 1998-07-27 2006-08-22 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
EP0997464A1 (en) * 1998-10-23 2000-05-03 Pfizer Inc. 1,3,8-Triazaspiro[4,5] decanone compounds as orl1-receptor agonists
US8394804B2 (en) 2001-10-19 2013-03-12 Janssen Pharmaceutica N.V. Phosphonic acid compounds as inhibitors of serine proteases
EP3138841A1 (en) * 2010-06-18 2017-03-08 Altos Therapeutics, LLC D2 antagonists, methods of synthesis and methods of use
IT201800007580A1 (it) * 2018-07-27 2020-01-27 Maria Cecilia Hospital Spa Composti 1,3,8-triazaspiro e loro uso come medicamenti
WO2020021378A1 (en) * 2018-07-27 2020-01-30 Maria Cecilia Hospital S.P.A. 1,3,8-triazaspiro compounds and their use as medicaments for the treatment of reperfusion injury

Also Published As

Publication number Publication date
DE1470125B2 (US06262066-20010717-C00359.png) 1979-10-31
CH462835A (de) 1968-09-30
NO117368B (US06262066-20010717-C00359.png) 1969-08-04
FR3059M (fr) 1965-01-11
FR2986M (fr) 1964-12-07
FI46967B (US06262066-20010717-C00359.png) 1973-05-02
DE1470125C3 (de) 1980-07-10
FR2988M (fr) 1964-12-07
SE311019B (US06262066-20010717-C00359.png) 1969-05-27
FI46967C (fi) 1973-08-10
DK119880B (da) 1971-03-08
FR3043M (fr) 1965-01-04
DE1470125A1 (de) 1969-05-08
FR2987M (fr) 1964-12-07
BE633914A (US06262066-20010717-C00359.png)
FR1573808A (US06262066-20010717-C00359.png) 1969-07-11

Similar Documents

Publication Publication Date Title
GB1043141A (en) Substituted-4-oxo-1, 3, 8-triazaspiro (4, 5) decanes and their therapeutically active non-toxic acid addition salts and the preparation thereof
ES430709A1 (es) Procedimiento para la obtencion de un medio fungicida a ba-se de derivados de 1-propil-imidazol.
GB929739A (en) N-substituted azaspiranes
GB961037A (en) Pyrazolones and processes for their preparation
ES279879A1 (es) Procedimiento para estabilizar el polipropileno contra el deterioro
US4328234A (en) Imidazole derivatives and salts thereof and pharmaceutical formulations useful in thrombo-embolic disorders
GB937732A (en) New aminopyrazoles and their use
GB842804A (en) Preparation of substituted piperazines
ES412847A1 (es) Procedimiento para la preparacion de 1-hidroxi-2-piridonas.
YU48294B (sh) Novi 1-(arilalkilaminoalkil)imidazoli i postupci za njihovo dobijanje
GB971661A (en) Dioxanes and dioxolanes
ATE12773T1 (de) 2-penem-verbindungen, sie enthaltende pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung.
ES480968A1 (es) Procedimiento para la preparacion de compuestos heterocicli-cos.
GB1137796A (en) New substituted benzo-1,4-oxazines products, their use and methods of manufacture
GB868987A (en) Morpholine compounds and their production
ES2004809A6 (es) Procedimiento de obtencion de nuevas 1-(2-(fenilmetil)fenil)piperazinas
GB901455A (en) C-substituted piperazinones and the manufacture thereof
GB868353A (en) Phenyl piperazine derivatives for therapeutic use and processes for the production of such derivatives
ES380026A2 (es) Produccion de 4 - fenilimino-i,4-dihidroquinolinas.
GB1078120A (en) Pharmaceutically valuable thiophene compounds
GB1010231A (en) Substituted 3-phenyl-5-imino-4,5 dihydro-1,2,4-oxadiazoles, process for their manufacture and therapeutic compositions containing same
GB1331130A (en) Dibenz-6,f-azocin-6-5h-ones
GB1009440A (en) Tetrahydropyridine derivatives and process for their production
GB1350939A (en) Styryltriazoles their use for the optical brightening or organic materials and processes for their manufacture
ES309176A1 (es) Procedimiento para la preparacion de nuevas amidas del acido ariloxiacetico.